arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Medpace Holdings, Inc.

MEDP
$617.63 ▼ -12.58 (-2.00%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
13 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
89
Health
Excellent
Bullish
auto_awesome

Analytical Summary

Medpace Holdings, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $17.8B
Dividend Yield —
Revenue Growth 20.0% ↗
Op. Margin 21.1% →
ROIC 96.9% ↗
FCF / Share $23.64 ↗
Trailing P/E 39.5x
Price / Book 38.2x
FCF Yield 3.8%
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

13-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.53B
↑ +20.0% —
Net Income Profit after all expenses
$451.12M
↑ +11.6% —
Operating Margin Operating profit as % of sales
21.1%
— -0.2% 77th
FCF / Share Free cash flow per share
$23.64
↑ +27.9% —
Long-Term Debt Long-term obligations
$0.00
↓ -100.0% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
82
Returns ↑
99
Cash Quality ↑
80

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 13 years · 46 quarters